The Directorate General of Drug Administration (DGDA), operating under the Ministry of Health & Family Welfare of the Government of the People's Republic of Bangladesh, serves as the national Drug Regulatory Authority. This Directorate is responsible for overseeing and enforcing all existing Drug Regulations within the country. It regulates a comprehensive range of activities, including the import and procurement of raw and packaging materials, the production and import of finished pharmaceutical products, as well as the export, sale, and pricing of all categories of medicines. This encompasses drugs from the Ayurvedic, Unani, Herbal, and Homoeopathic systems of medicine.

Currently, the country hosts 317 Allopathic, 208 Ayurvedic, 286 Unani, 44 Herbal, and 71 Homoeopathic drug manufacturing companies. The DGDA is tasked with monitoring and regulating the operations of all 926 companies. The Director General, who heads the Directorate, is vested with the authority by the Government to act as the Licensing Authority (LA) for drugs. This role includes the issuance of licenses for the manufacture, storage, sale, import, and export of drugs and medicines.

The DGDA operates through 47 district offices across the country. All officers within the Directorate are designated as "Drug Inspectors" under the Drug Laws and assist the Licensing Authority in the effective discharge of its duties. Additionally, several specialized committees, such as the Drug Control Committee (DCC), the Standing Committee for the procurement and import of raw materials and finished drugs, the Pricing Committee, and other relevant committees composed of experts, provide advisory support to the Licensing Authority. These committees offer recommendations on matters pertaining to drugs and medicines, ensuring a robust regulatory framework.